company background image
2873 logo

Guiyang Xintian PharmaceuticalLtd SZSE:002873 Stock Report

Last Price

CN¥11.44

Market Cap

CN¥2.6b

7D

2.3%

1Y

-16.6%

Updated

26 Apr, 2024

Data

Company Financials +

Guiyang Xintian Pharmaceutical Co.,Ltd.

SZSE:002873 Stock Report

Market Cap: CN¥2.6b

2873 Stock Overview

Guiyang Xintian Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of new Chinese patent medicines for various diseases in China.

2873 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance2/6
Financial Health3/6
Dividends1/6

Guiyang Xintian Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Guiyang Xintian PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥11.44
52 Week HighCN¥15.24
52 Week LowCN¥7.59
Beta-0.12
1 Month Change-8.41%
3 Month Change6.32%
1 Year Change-16.56%
3 Year Change28.27%
5 Year Change31.20%
Change since IPO43.79%

Recent News & Updates

Weak Statutory Earnings May Not Tell The Whole Story For Guiyang Xintian PharmaceuticalLtd (SZSE:002873)

Apr 19
Weak Statutory Earnings May Not Tell The Whole Story For Guiyang Xintian PharmaceuticalLtd (SZSE:002873)

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Guiyang Xintian PharmaceuticalLtd (SZSE:002873)

Apr 19
Weak Statutory Earnings May Not Tell The Whole Story For Guiyang Xintian PharmaceuticalLtd (SZSE:002873)

Investors Still Aren't Entirely Convinced By Guiyang Xintian Pharmaceutical Co.,Ltd.'s (SZSE:002873) Earnings Despite 28% Price Jump

Mar 11
Investors Still Aren't Entirely Convinced By Guiyang Xintian Pharmaceutical Co.,Ltd.'s (SZSE:002873) Earnings Despite 28% Price Jump

Shareholder Returns

2873CN PharmaceuticalsCN Market
7D2.3%3.3%-0.3%
1Y-16.6%-14.4%-14.6%

Return vs Industry: 002873 underperformed the CN Pharmaceuticals industry which returned -14.4% over the past year.

Return vs Market: 002873 underperformed the CN Market which returned -14.6% over the past year.

Price Volatility

Is 2873's price volatile compared to industry and market?
2873 volatility
2873 Average Weekly Movement10.5%
Pharmaceuticals Industry Average Movement7.6%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.2%

Stable Share Price: 002873's share price has been volatile over the past 3 months.

Volatility Over Time: 002873's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19951,958Da Lun Dongwww.gyxtyy.com

Guiyang Xintian Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of new Chinese patent medicines for various diseases in China. The company offers formulation products, which include hard capsules, granules, tablets, mixtures, syrups, liquors, dews, powders, suspensions, and gels.

Guiyang Xintian Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Guiyang Xintian PharmaceuticalLtd's earnings and revenue compare to its market cap?
2873 fundamental statistics
Market capCN¥2.62b
Earnings (TTM)CN¥80.87m
Revenue (TTM)CN¥953.98m

32.6x

P/E Ratio

2.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2873 income statement (TTM)
RevenueCN¥953.98m
Cost of RevenueCN¥219.39m
Gross ProfitCN¥734.59m
Other ExpensesCN¥653.72m
EarningsCN¥80.87m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 27, 2024

Earnings per share (EPS)0.35
Gross Margin77.00%
Net Profit Margin8.48%
Debt/Equity Ratio52.9%

How did 2873 perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

20%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.